Hui Li Ang

1.2k total citations · 1 hit paper
13 papers, 862 citations indexed

About

Hui Li Ang is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Hui Li Ang has authored 13 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Biomedical Engineering. Recurrent topics in Hui Li Ang's work include Cancer Mechanisms and Therapy (2 papers), RNA Interference and Gene Delivery (2 papers) and Curcumin's Biomedical Applications (2 papers). Hui Li Ang is often cited by papers focused on Cancer Mechanisms and Therapy (2 papers), RNA Interference and Gene Delivery (2 papers) and Curcumin's Biomedical Applications (2 papers). Hui Li Ang collaborates with scholars based in Singapore, Türkiye and Iran. Hui Li Ang's co-authors include Alan Prem Kumar, Ali Zarrabi, Milad Ashrafizadeh, Kiavash Hushmandi, Amirhossein Zabolian, Pooyan Makvandi, Gautam Sethi, Hossein Saleki, Ebrahim Rahmani Moghadam and Haroon Khan and has published in prestigious journals such as International Journal of Molecular Sciences, CHEST Journal and Life Sciences.

In The Last Decade

Hui Li Ang

13 papers receiving 857 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds

2023 137 citations Hui Li Ang, Chakrabhavi Dhananjaya Mohan et al. Medicinal Research Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hui Li Ang Singapore	12	500	245	142	91	78	13	862
Ebrahim Rahmani Moghadam Iran	13	568 1.1×	319 1.3×	170 1.2×	107 1.2×	87 1.1×	18	946
Mehdi Sabzichi Iran	14	406 0.8×	165 0.7×	101 0.7×	150 1.6×	75 1.0×	18	815
Cristian Moldovan Romania	17	322 0.6×	179 0.7×	173 1.2×	91 1.0×	120 1.5×	53	854
Bijesh Kumar Biswal India	18	541 1.1×	144 0.6×	140 1.0×	67 0.7×	87 1.1×	49	966
Chi-Chung Wang Taiwan	11	417 0.8×	156 0.6×	132 0.9×	71 0.8×	80 1.0×	12	889
Samik Chakraborty India	21	654 1.3×	329 1.3×	281 2.0×	59 0.6×	96 1.2×	37	1.2k
Shilpi Saha India	16	486 1.0×	160 0.7×	253 1.8×	71 0.8×	50 0.6×	20	987
Yaghoub Yazdani Iran	15	427 0.9×	153 0.6×	113 0.8×	86 0.9×	49 0.6×	47	885
Kobra Velaei Iran	14	400 0.8×	159 0.6×	202 1.4×	62 0.7×	88 1.1×	20	827
Hassan Dariushnejad Iran	17	453 0.9×	103 0.4×	126 0.9×	123 1.4×	48 0.6×	47	908

Countries citing papers authored by Hui Li Ang

Since Specialization

Citations

This map shows the geographic impact of Hui Li Ang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Li Ang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Li Ang more than expected).

Fields of papers citing papers by Hui Li Ang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Li Ang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Li Ang. The network helps show where Hui Li Ang may publish in the future.

Co-authorship network of co-authors of Hui Li Ang

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Li Ang. A scholar is included among the top collaborators of Hui Li Ang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Li Ang. Hui Li Ang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Ang, Hui Li, et al.. (2024). Pulmonary Hypertension in Interstitial Lung Disease. CHEST Journal. 166(4). 778–792. 4 indexed citations

Ang, Hui Li, Chakrabhavi Dhananjaya Mohan, Muthu K. Shanmugam, et al.. (2023). Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds. Medicinal Research Reviews. 43(4). 1141–1200. 137 indexed citations breakdown →

Paskeh, Mahshid Deldar Abad, Hamidreza Saebfar, Mahmood Khaksary Mahabady, et al.. (2022). Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy. Life Sciences. 298. 120463–120463. 44 indexed citations

Ashrafizadeh, Milad, Ali Zarrabi, Sepideh Mirzaei, et al.. (2021). Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery. Food and Chemical Toxicology. 157. 112576–112576. 92 indexed citations

Mirzaei, Sepideh, Mohammad Gholami, Hui Li Ang, et al.. (2021). Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy. Cells. 10(12). 3348–3348. 46 indexed citations

Ashrafizadeh, Milad, Ali Zarrabi, Farid Hashemi, et al.. (2020). Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity. Pharmaceutics. 12(11). 1084–1084. 97 indexed citations

Moghadam, Ebrahim Rahmani, Hui Li Ang, Amirhossein Zabolian, et al.. (2020). Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives. Biomolecules. 10(10). 1374–1374. 63 indexed citations

Ashrafizadeh, Milad, Hui Li Ang, Ebrahim Rahmani Moghadam, et al.. (2020). MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy. Biomolecules. 10(7). 1040–1040. 72 indexed citations

Ashrafizadeh, Milad, Masoud Najafi, Hui Li Ang, et al.. (2020). PTEN, a Barrier for Proliferation and Metastasis of Gastric Cancer Cells: From Molecular Pathways to Targeting and Regulation. Biomedicines. 8(8). 264–264. 62 indexed citations

10.

Chai, Yuek Ling, Wee Siong Chew, Joyce R. Chong, et al.. (2020). Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer’s disease and vascular cognitive impairment. Alzheimer s Research & Therapy. 12(1). 122–122. 31 indexed citations

11.

Ang, Hui Li, Yi Yuan, Xianning Lai, et al.. (2020). Putting the BRK on breast cancer: From molecular target to therapeutics. Theranostics. 11(3). 1115–1128. 19 indexed citations

12.

Harsha, Choudhary, Kishore Banik, Hui Li Ang, et al.. (2020). Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials. International Journal of Molecular Sciences. 21(9). 3285–3285. 162 indexed citations

13.

Ang, Hui Li, et al.. (2019). Magneto‐Fluorescent Perovskite Nanocomposites for Directed Cell Motion and Imaging. Advanced Healthcare Materials. 8(23). e1900859–e1900859. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact